REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,573,740 | +1.0% | 79,905 | -15.4% | 0.51% | -8.7% |
| Q3 2022 | $2,549,000 | +138.4% | 94,413 | +122.0% | 0.55% | +119.0% |
| Q3 2020 | $1,069,000 | +38.8% | 42,537 | +34.8% | 0.25% | +48.8% |
| Q2 2020 | $770,000 | -39.0% | 31,552 | -63.0% | 0.17% | -56.6% |
| Q1 2020 | $1,262,000 | -26.2% | 85,302 | -19.1% | 0.39% | +4.3% |
| Q4 2019 | $1,711,000 | -50.9% | 105,429 | -6.8% | 0.38% | -35.2% |
| Q1 2018 | $3,483,000 | -9.2% | 113,096 | +5.4% | 0.58% | -15.6% |
| Q4 2017 | $3,837,000 | +92.0% | 107,333 | +48.0% | 0.69% | +158.3% |
| Q3 2017 | $1,998,000 | +123.2% | 72,518 | +113.9% | 0.27% | +79.7% |
| Q2 2017 | $895,000 | -74.5% | 33,897 | -67.0% | 0.15% | -67.8% |
| Q4 2015 | $3,512,000 | +96.1% | 102,800 | +95.2% | 0.46% | +35.0% |
| Q2 2014 | $1,791,000 | – | 52,668 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |